ER stress-inducible ATF3 suppresses BMP2-induced ALP expression and activation in MC3T3-E1 cells

Cited 28 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorJae Kyung Park-
dc.contributor.authorHoon Jang-
dc.contributor.authorS Hwang-
dc.contributor.authorE J Kim-
dc.contributor.authorDong Ern Kim-
dc.contributor.authorK B Oh-
dc.contributor.authorD J Kwon-
dc.contributor.authorJ T Koh-
dc.contributor.authorK Kimura-
dc.contributor.authorH Inoue-
dc.contributor.authorW G Jang-
dc.contributor.authorJeong Woong Lee-
dc.date.accessioned2017-04-19T09:49:39Z-
dc.date.available2017-04-19T09:49:39Z-
dc.date.issued2014-
dc.identifier.issn0006-291X-
dc.identifier.uri10.1016/j.bbrc.2013.11.121ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/11763-
dc.description.abstractEndoplasmic reticulum (ER) stress suppresses osteoblast differentiation. Activating transcription factor (ATF) 3, a member of the ATF/cAMP response element-binding protein family of transcription factors, is induced by various stimuli including cytokines, hormones, DNA damage, and ER stress. However, the role of ATF3 in osteoblast differentiation has not been elucidated. Treatment with tunicamycin (TM), an ER stress inducer, increased ATF3 expression in the preosteoblast cell line, MC3T3-E1. Overexpression of ATF3 inhibited bone morphogenetic protein 2-stimulated expression and activation of alkaline phosphatase (ALP), an osteogenic marker. In addition, suppression of ALP expression by TM treatment was rescued by silencing of ATF3 using shRNA. Taken together, these data indicate that ATF3 is a novel negative regulator of osteoblast differentiation by specifically suppressing ALP gene expression in preosteoblasts.-
dc.publisherElsevier-
dc.titleER stress-inducible ATF3 suppresses BMP2-induced ALP expression and activation in MC3T3-E1 cells-
dc.title.alternativeER stress-inducible ATF3 suppresses BMP2-induced ALP expression and activation in MC3T3-E1 cells-
dc.typeArticle-
dc.citation.titleBiochemical and Biophysical Research Communications-
dc.citation.number1-
dc.citation.endPage338-
dc.citation.startPage333-
dc.citation.volume443-
dc.contributor.affiliatedAuthorJae Kyung Park-
dc.contributor.affiliatedAuthorHoon Jang-
dc.contributor.affiliatedAuthorDong Ern Kim-
dc.contributor.affiliatedAuthorJeong Woong Lee-
dc.contributor.alternativeName박재경-
dc.contributor.alternativeName장훈-
dc.contributor.alternativeName황성수-
dc.contributor.alternativeName김은정-
dc.contributor.alternativeName김동언-
dc.contributor.alternativeName오건봉-
dc.contributor.alternativeName권대진-
dc.contributor.alternativeName고정태-
dc.contributor.alternativeNameKimura-
dc.contributor.alternativeNameInoue-
dc.contributor.alternativeName장원구-
dc.contributor.alternativeName이정웅-
dc.identifier.bibliographicCitationBiochemical and Biophysical Research Communications, vol. 443, no. 1, pp. 333-338-
dc.identifier.doi10.1016/j.bbrc.2013.11.121-
dc.subject.keywordActivating transcription factor 3 (ATF3)-
dc.subject.localactivating transcription factor 3 (ATF3)-
dc.subject.localActivating transcription factor 3 (ATF3)-
dc.description.journalClassY-
Appears in Collections:
Division of A.I. & Biomedical Research > Biotherapeutics Translational Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.